Jill Andersen
General Counsel chez INVIVYD, INC.
Fortune : 11 988 $ au 31/03/2024
Profil
Jill Andersen is currently working as the Secretary & Chief Legal Officer at Invivyd, Inc. Previously, she held the position of Vice President & Head-Legal at Bristol Myers Squibb Co. from 2019 to 2020 and at Celgene Corp.
from 2016 to 2020.
She also worked as a Litigation Associate at Davis Polk & Wardwell LLP from 1994 to 1996 and as VP, General Counsel, Head-Legal & Intellectual at Novartis Services, Inc. in 2015 to 2016.
Additionally, she served as the Chief Compliance Officer & General Counsel at Oyster Point Pharma, Inc. from 2020 to 2021.
Ms. Andersen completed her undergraduate degree at Boston College and obtained her graduate degree from Wake Forest University School of Law.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INVIVYD, INC.
0,00% | 18/12/2023 | 2 700 ( 0,00% ) | 11 988 $ | 31/03/2024 |
Postes actifs de Jill Andersen
| Sociétés | Poste | Début |
|---|---|---|
| INVIVYD, INC. | General Counsel | 22/11/2021 |
Anciens postes connus de Jill Andersen
| Sociétés | Poste | Fin |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | General Counsel | 01/05/2020 |
| CELGENE | General Counsel | 01/05/2020 |
| Novartis Services, Inc. | General Counsel | 01/09/2016 |
Davis Polk & Wardwell LLP
 Davis Polk & Wardwell LLP Miscellaneous Commercial ServicesCommercial Services Davis Polk & Wardwell LLP provides legal services. It offers legal solutions to areas such as capital markets, mergers and acquisitions, credit, insolvency, and restructuring, investment management, tax, and litigation. The company was founded by Francis N. Bangs in 1849 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/1996 |
| OYSR POIN | Compliance Officer | - |
Formation de Jill Andersen
| Boston College | Undergraduate Degree |
| Wake Forest University School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| INVIVYD, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Davis Polk & Wardwell LLP
Davis Polk & Wardwell LLP Miscellaneous Commercial ServicesCommercial Services Davis Polk & Wardwell LLP provides legal services. It offers legal solutions to areas such as capital markets, mergers and acquisitions, credit, insolvency, and restructuring, investment management, tax, and litigation. The company was founded by Francis N. Bangs in 1849 and is headquartered in New York, NY. | Commercial Services |
Oyster Point Pharma, Inc.
 Oyster Point Pharma, Inc. Pharmaceuticals: MajorHealth Technology Oyster Point Pharma, Inc. engages in the development and commercialization of pharmaceutical therapies to treat ocular surface diseases. Its product candidate, OC-01, is a nicotinic acetylcholine receptor agonist, which is being developed as a nasal spray to treat the signs and symptoms of dry eye disease. The company was founded by Michael and is Ackermann in June 30, 2015 headquartered in Princeton, NJ. | Health Technology |
| Novartis Services, Inc. |
